ZA200501084B - Dispersible tablets for oral administration - Google Patents

Dispersible tablets for oral administration

Info

Publication number
ZA200501084B
ZA200501084B ZA200501084A ZA200501084A ZA200501084B ZA 200501084 B ZA200501084 B ZA 200501084B ZA 200501084 A ZA200501084 A ZA 200501084A ZA 200501084 A ZA200501084 A ZA 200501084A ZA 200501084 B ZA200501084 B ZA 200501084B
Authority
ZA
South Africa
Prior art keywords
oral administration
dispersible tablets
dispersible
tablets
oral
Prior art date
Application number
ZA200501084A
Other languages
English (en)
Inventor
Shashikanth B S Isloor
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200501084B publication Critical patent/ZA200501084B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
ZA200501084A 2002-07-16 2006-01-24 Dispersible tablets for oral administration ZA200501084B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN753DE2002 2002-07-16

Publications (1)

Publication Number Publication Date
ZA200501084B true ZA200501084B (en) 2006-03-29

Family

ID=30012265

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501084A ZA200501084B (en) 2002-07-16 2006-01-24 Dispersible tablets for oral administration

Country Status (10)

Country Link
US (1) US20060110445A1 (ru)
EP (1) EP1539146A1 (ru)
KR (1) KR20050062514A (ru)
CN (1) CN1681497A (ru)
AU (1) AU2003249116A1 (ru)
BR (1) BR0312728A (ru)
EA (1) EA200500213A1 (ru)
MX (1) MXPA05000641A (ru)
WO (1) WO2004006917A1 (ru)
ZA (1) ZA200501084B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same
TR201002878A2 (tr) * 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil içeren farmasötik bileşimler.
WO2011152808A1 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Formulation comprising cefpodoxime proxetil and clavulanic acid
TR201007107A1 (tr) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
TR201007106A1 (tr) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil formülasyonları.
TR201009167A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefalosporin içeren farmasötik granüller.
TR201010860A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir formulasyonları için üretim yöntemi.
TR201009168A2 (tr) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Suda dağılan sefpodoksim proksetil formülasyonları.
WO2013001541A1 (en) * 2011-06-30 2013-01-03 Aggarwal Kumar Vijay An optimized bilayered tablet dosage form with high rate of bioavailability of two active antibiotics: cefuroxime and clavulanic acid
WO2013001543A1 (en) * 2011-06-30 2013-01-03 Aggarwal Kumar Vijay An optimized bilayered tablet dosage form with two active antibiotics: clavulanic acid and cefpodoxime
CN102488668A (zh) * 2011-12-29 2012-06-13 山东淄博新达制药有限公司 头孢呋辛酯分散片剂及其制备方法
CN102697747A (zh) * 2012-06-13 2012-10-03 广州南新制药有限公司 一种头孢呋辛酯的分散片
WO2014023710A1 (en) 2012-08-07 2014-02-13 Sandoz Ag UNCOATED TABLET COMPRISING GRANULES INCLUDING A β-LACTAM ANTIBIOTIC AND HIGHLY DISPERSED SILICONE DIOXIDE
CN104473922B (zh) * 2013-07-16 2018-05-01 上海汉维生物医药科技有限公司 复方片剂及其制备方法
CN104546838B (zh) * 2013-07-16 2018-05-01 上海汉维生物医药科技有限公司 片剂及其制备方法
CN103340855B (zh) * 2013-07-16 2015-01-07 上海汉维生物医药科技有限公司 复方阿莫西林克拉维酸钾片剂及其制备方法
WO2015070131A1 (en) * 2013-11-11 2015-05-14 Forest Laboratories Holdings Limited Compositions and methods of treatment comprising fosfomycin disodium
CN104257618B (zh) * 2014-09-26 2017-01-11 山东新时代药业有限公司 一种含有法罗培南钠的口腔崩解片及其制备方法
CN113398083A (zh) * 2021-06-24 2021-09-17 山东淄博新达制药有限公司 一种头孢呋辛酯分散片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552416A (en) * 1975-08-12 1979-09-12 Beecham Group Ltd Pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6361794B1 (en) * 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
CA2280857A1 (en) * 1997-02-14 1998-08-20 Smithkline Beecham Laboratoires Pharmaceutiques Pharmaceutical formulations comprising amoxocyllin and clavulanate
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
CA2433962C (en) * 2002-07-19 2012-10-30 Abbott Laboratories Antibacterial clarithromycin compositions and processes for making the same

Also Published As

Publication number Publication date
US20060110445A1 (en) 2006-05-25
AU2003249116A1 (en) 2004-02-02
KR20050062514A (ko) 2005-06-23
CN1681497A (zh) 2005-10-12
WO2004006917A1 (en) 2004-01-22
MXPA05000641A (es) 2005-04-19
EP1539146A1 (en) 2005-06-15
BR0312728A (pt) 2005-04-26
EA200500213A1 (ru) 2005-08-25

Similar Documents

Publication Publication Date Title
ZA200501084B (en) Dispersible tablets for oral administration
EG25453A (en) Deferacirox dispersible tablets
HK1081457A1 (en) Dispersible pharmaceutical compositions
HK1085131A1 (en) Solid drug for oral use
IL164519A0 (en) Pharmaceutical formulations
AU3574500A (en) Rapidly disintegrable tablet for oral administration
EP1553925A4 (en) ORAL DOSAGE FORM WITH MODIFIED RELEASE
PL364621A1 (en) Nicotine-containing oral dosage form
PT1362582E (pt) Forma de dosagem sólida revestida
HUP0400850A3 (en) Oral pharmaceutical compositions
IL166337A0 (en) Oral administration of calctionin
GB0209668D0 (en) Oral devices
GB2392093B (en) Pharmaceutical formulations
HUP0500638A3 (en) Flashmelt oral dosage formulation
HK1072194A1 (en) Oral dosage form for controlled drug release
IL162510A0 (en) Pharmaceutical suspension for oral administration
HUP0401599A3 (en) Extended release oral dosage form
EP1357898A4 (en) ORAL DOSAGE FORM WITH ENHANCED REGULATED RELEASE
AU2003244092A1 (en) 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
EP1491189A4 (en) ORAL PHARMACEUTICALS WITH DICLOFENAC SODIUM
ZA200204905B (en) Improved pharmaceutical dental formulations.
IL165843A0 (en) Popping oral administration form
SG103334A1 (en) Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole
GB0218994D0 (en) Oral pharmaceutical compositions
EP1531847A4 (en) PHARMACEUTICAL FORMULATION